Camrelizumab-Related Lethal Arrhythmias and Myasthenic Crisis in a Patient with Metastatic Thymoma

Immune checkpoint inhibitors (ICIs) have emerged in recent years as promising treatment options for several malignant tumors. However, ICI therapy has also been associated with various immune-related adverse events (irAEs), especially for patients with preexisting autoimmune status, which sometimes...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Bo, Gyawali, Laxman, Liu, Zengzhang, Du, Huaan, Yin, Yuehui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411010/
https://www.ncbi.nlm.nih.gov/pubmed/36032051
http://dx.doi.org/10.1155/2022/4042909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411010/
https://www.ncbi.nlm.nih.gov/pubmed/36032051
http://dx.doi.org/10.1155/2022/4042909

Ejemplares similares